WOONSOCKET, R.I.--(BUSINESS WIRE)--May 24, 2006--Onset Therapeutics, a specialty pharmaceutical company that focuses on the development and commercialization of innovative treatments for skin and wound related disorders, announced today that they have launched Optase (TM), the first in a series of prescription products expected to be introduced to the rapidly growing wound care market. Optase (TM) will be targeted primarily to the long term care market (e.g. Nursing Homes) and acute wound care clinics.
